1/16
Looks like no tags are added yet.
Name | Mastery | Learn | Test | Matching | Spaced |
|---|
No study sessions yet.
What are the two main types of neurotransmission?
Electrical (gap junctions) and chemical
Differences between electrical and chemical synapse
distance between pre and post synaptic membrane
type of transmission
synaptic delay?
uni or bidirectional?
Electrical: <5nm, by ion current, no, bidirectional
Chemical: 20-40nm, by chemical neurotransmitter, yes 0.3-5ms, unidirectional
What structure enables direct electrical transmission?
Connexons (6 identical protein subunits forming gap junction channels).
Explain steps of chemical neurotransmission (5)
AP depolarizes the nerve terminal
VGCC opened
Calcium enter the nerve terminal increasing calcium conc inside
Neurotransmitters released by exocytosis
Neurotransmitters react with ligand gated channels in post synaptic cell membrane
What 3 proteins bind Ca²⁺ and their functions?
TCS
Troponin – skeletal muscle contraction
Calmodulin – smooth muscle contraction & gland secretion
Synaptotagmin – triggers neurotransmitter release
How do voltage-gated Ca²⁺ channels differ from Na⁺ channels?
Ca²⁺ channels open more slowly but trigger cellular processes by binding to proteins.
What is the active zone?
What are docked vesicles?
What is meant by “quantal release”?
The presynaptic site where vesicles release neurotransmitter, rich in Ca²⁺ channels.
Vesicles positioned at the presynaptic membrane ready for release.
Neurotransmitter is released in discrete packets, each representing one vesicle’s contents
How are vesicles released step by step (6)
Docking: Vesicles sit at the active zone.
Priming: v-SNAREs pair with t-SNAREs.
Trigger: Ca2+Ca^{2+}Ca2+ enters and binds synaptotagmin.
Action: Synaptotagmin drives SNARE “zippering.”
Fusion: Membranes merge → contents released.
Reset: NSF + ATP disassemble SNAREs for reuse.
What are the three vesicle release/recycling pathways?
KS
KR
E
Kiss-and-stay: Vesicle releases contents and stays docked.
Kiss-and-run: Vesicle detaches, refilled, and reused.
Endocytosis via endosomes: Vesicle fully recycled.
What are the criteria that define a neurotransmitter? (5)
Synthesized in presynaptic cell & stored in vesicles
Released upon stimulation
Specific receptor on postsynaptic cell
Application mimics natural effect
Blocking it inhibits normal function
What are the five major classes of neurotransmitters?
ACNPF
Simple amino acids – glutamate, glycine, GABA, aspartate
Classical – ACh, serotonin, dopamine, noradrenaline, adrenaline
Neuropeptides – insulin, glucagon, bradykinin, hypothalamic hormones
Purines/pyrimidines – ATP, adenine, guanine
Free radical gas – nitric oxide (NO)
Give examples of receptor types for ACh and noradrenaline.
ACh → Nicotinic (N-cholinergic) or Muscarinic (M-cholinergic)
NA/Adr → α and β adrenergic receptors
α = smooth muscle contraction
β = smooth muscle relaxation
What are ionotropic and metabotropic receptors, their speed and examples
Ligand gated ion channels, fast, eg nicotinic
G protein coupled receptors, slow, modulatory eg adrenergic alpha and beta
Characteristics of a neuromuscular junction (5)
has a motor end plate
simple
easily accessible
large
one muscle cell innervated by one axon
What are the possible fates of neurotransmitters after release? (3)
DER
How is Ach recycled?
Diffusion away from synaptic cleft
Enzymatic degradation (e.g. AChE (acetylcholinesterase) breaks down ACh)
Reuptake into presynaptic terminal via transporters for reuse or degradation
AChE breaks it down into acetate + choline → choline reuptaken by chloine transporter on pre synaptic terminal and reused to synthesize new ACh using cohylnacetylesterase.
What causes Lambert-Eaton syndrome and how is it treated?
Antibodies against voltage-gated Ca²⁺ channels → reduced ACh release.
By decreasing ACh breakdown (pyridostigmine) or increasing Ca²⁺ influx (3,4-diaminopyridine).
What causes Myasthenia Gravis and how is it treated?
Antibodies against nicotinic ACh receptors → fewer functional receptors.
AChE inhibitors (pyridostigmine, neostigmine) to prolong ACh action.